![Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology | American Society of Nephrology Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology | American Society of Nephrology](https://kidney360.asnjournals.org/content/kidney360/1/5/359/F1.large.jpg)
Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology | American Society of Nephrology
![A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2004293341/2017814654/gr3.jpg)
A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
![Rituximab (RTX) stimulation induces SHP-1 recruitment to CD16 z chain.... | Download Scientific Diagram Rituximab (RTX) stimulation induces SHP-1 recruitment to CD16 z chain.... | Download Scientific Diagram](https://www.researchgate.net/profile/Rosa-Molfetta-2/publication/280582156/figure/fig4/AS:280886995111937@1443980086030/Rituximab-RTX-stimulation-induces-SHP-1-recruitment-to-CD16-z-chain-SHP-1-inhibition.png)
Rituximab (RTX) stimulation induces SHP-1 recruitment to CD16 z chain.... | Download Scientific Diagram
![specificity for rituximab (rtx) and infliximab (ifx) peptides of the... | Download Scientific Diagram specificity for rituximab (rtx) and infliximab (ifx) peptides of the... | Download Scientific Diagram](https://www.researchgate.net/publication/316742582/figure/fig2/AS:614280093265920@1523467195003/specificity-for-rituximab-rtx-and-infliximab-ifx-peptides-of-the-cD4-T-cells.png)
specificity for rituximab (rtx) and infliximab (ifx) peptides of the... | Download Scientific Diagram
![Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study - ACR Meeting Abstracts Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2014/10/Paper-28178-abstract-27709-0.jpg)
Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study - ACR Meeting Abstracts
![Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12948-019-0113-3/MediaObjects/12948_2019_113_Fig1_HTML.png)
Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text
![Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig3_HTML.png)
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
![Rituximab Prolongs the Time to Relapse in Patients with Immune Thrombotic Thrombocytopenic Purpura: Analysis of Off-Label Use in Japan - ISTH Congress Abstracts Rituximab Prolongs the Time to Relapse in Patients with Immune Thrombotic Thrombocytopenic Purpura: Analysis of Off-Label Use in Japan - ISTH Congress Abstracts](https://abstracts.isth.org/wp-content/uploads/2020/06/p_1120_1000029.jpg)
Rituximab Prolongs the Time to Relapse in Patients with Immune Thrombotic Thrombocytopenic Purpura: Analysis of Off-Label Use in Japan - ISTH Congress Abstracts
![Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis - The Journal of Allergy and Clinical Immunology: In Practice Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis - The Journal of Allergy and Clinical Immunology: In Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/eab6356c-31b3-4dd8-b7c3-0fc409c0fa3f/gr1.jpg)
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis - The Journal of Allergy and Clinical Immunology: In Practice
![In vitro and in vivo treatment with rituximab (RTX) leads to CD20KO... | Download Scientific Diagram In vitro and in vivo treatment with rituximab (RTX) leads to CD20KO... | Download Scientific Diagram](https://www.researchgate.net/publication/349166570/figure/fig4/AS:995501566590977@1614357477657/In-vitro-and-in-vivo-treatment-with-rituximab-RTX-leads-to-CD20KO-phenotype-A-Flow.png)
In vitro and in vivo treatment with rituximab (RTX) leads to CD20KO... | Download Scientific Diagram
טוויטר \ ERA - European Renal Association בטוויטר: "Pierre Ronco. Rituximab in membranous nephropathy. MENTOR-trial. Rtx is as effective as Cs in inducing C/PR #ERAEDTA18 #RITUXIMAB #RtxGlomerulardisease https://t.co/Ein148uebM"
![Rituximab (RTX) treatment correlates with significant attenuation of... | Download Scientific Diagram Rituximab (RTX) treatment correlates with significant attenuation of... | Download Scientific Diagram](https://www.researchgate.net/publication/303467017/figure/fig4/AS:373644472668162@1466095192125/Rituximab-RTX-treatment-correlates-with-significant-attenuation-of-transforming-growth.png)
Rituximab (RTX) treatment correlates with significant attenuation of... | Download Scientific Diagram
![Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity - Multiple Sclerosis and Related Disorders Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity - Multiple Sclerosis and Related Disorders](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/f2378a97-ba81-498b-8f1d-a57d4f2df359/gr1.jpg)
Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity - Multiple Sclerosis and Related Disorders
![Percentage of apoptosis in untreated versus rituximab (RTX)-treated... | Download Scientific Diagram Percentage of apoptosis in untreated versus rituximab (RTX)-treated... | Download Scientific Diagram](https://www.researchgate.net/profile/Michael-Centola/publication/8471126/figure/fig1/AS:267721455697958@1440841177264/Percentage-of-apoptosis-in-untreated-versus-rituximab-RTX-treated-peripheral-blood-B.png)
Percentage of apoptosis in untreated versus rituximab (RTX)-treated... | Download Scientific Diagram
![Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease - European Journal of Internal Medicine Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease - European Journal of Internal Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/26443312-9414-42e3-ae0b-cdfd562e4db8/gr1_lrg.jpg)
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease - European Journal of Internal Medicine
![ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated Vasculitis Patients - ACR Meeting Abstracts ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated Vasculitis Patients - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2019/08/GTUOHVCE-694107-1-ANY-3-.jpg)
ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated Vasculitis Patients - ACR Meeting Abstracts
![Hypersialylation characterizes CLL cells resistant to rituximab (RTX)... | Download Scientific Diagram Hypersialylation characterizes CLL cells resistant to rituximab (RTX)... | Download Scientific Diagram](https://www.researchgate.net/profile/Yves-Renaudineau/publication/326842632/figure/fig4/AS:656719470395392@1533585531602/Hypersialylation-characterizes-CLL-cells-resistant-to-rituximab-RTX-induced.png)
Hypersialylation characterizes CLL cells resistant to rituximab (RTX)... | Download Scientific Diagram
![Level of rituximab (RTX) and B cells after initiation of RTX therapy in... | Download Scientific Diagram Level of rituximab (RTX) and B cells after initiation of RTX therapy in... | Download Scientific Diagram](https://www.researchgate.net/profile/Jasper-Stevens/publication/278047551/figure/fig1/AS:294318574194698@1447182424399/Level-of-rituximab-RTX-and-B-cells-after-initiation-of-RTX-therapy-in-nephrotic.png)
Level of rituximab (RTX) and B cells after initiation of RTX therapy in... | Download Scientific Diagram
![Del(17p) influences the pharmacokinetics of rituximab (RTX). Del(17p)... | Download Scientific Diagram Del(17p) influences the pharmacokinetics of rituximab (RTX). Del(17p)... | Download Scientific Diagram](https://www.researchgate.net/publication/330720431/figure/fig1/AS:720582769405953@1548811728343/Del17p-influences-the-pharmacokinetics-of-rituximab-RTX-Del17p-CLL-patients-have-a.png)